Universal-Beteiligungs- und Servicegesellschaft’s United Therapeutics UTHR Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.84M	Sell	18,152 -5,228	-22%	-$2.94M	0.02%	660
2026 Q1	$13.9M	Buy	23,380 +3,962	+20%	+$1.97M	0.02%	497
2025 Q4	$9.48M	Sell	19,418 -19,657	-50%	-$9.15M	0.02%	637
2025 Q3	$16.4M	Sell	39,075 -4,619	-11%	-$1.55M	0.03%	442
2025 Q2	$12.6M	Sell	43,694 -2,996	-6%	-$895K	0.02%	507
2025 Q1	$14.4M	Sell	46,690 -87	-0.2%	-$29.8K	0.03%	453
2024 Q4	$16.5M	Buy	+46,777	New	+$17.2M	0.03%	407

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's UTHR Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its United Therapeutics (UTHR) stake by 22% in Q2 2026, selling an estimated $2.94M and leaving 18,152 shares worth $9.84M. The position accounts for 0.02% of the portfolio, ranked #660.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in UTHR in Q4 2024 and has held it in 7 quarters since. The position peaked at $16.5M in Q4 2024. 559 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft held 18,152 shares of United Therapeutics worth $9.84M as of Q2 2026.
Universal-Beteiligungs- und Servicegesellschaft sold 5,228 United Therapeutics shares in Q2 2026, an estimated $2.94M.
United Therapeutics made up 0.02% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #660 holding.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in United Therapeutics in Q4 2024 and has held it in 7 quarters since.
Universal-Beteiligungs- und Servicegesellschaft's United Therapeutics position peaked at $16.5M in Q4 2024.
559 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.